Engineering of human pluripotent stem cells by AAV-mediated gene targeting. - Wikidata - awgldk - TriplyDB

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

http://www.wikidata.org/entity/Q33930075

about

A rapid FACS-based strategy to isolate human gene knockin and knockout clones Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)Primary skin fibroblasts as a model of Parkinson's disease Hematopoietic stem cell engineering at a crossroads HLA engineering of human pluripotent stem cells Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.Viral single-strand DNA induces p53-dependent apoptosis in human embryonic stem cells.Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.Targeting of the human coagulation factor IX gene at rDNA locus of human embryonic stem cells.Adeno-associated virus: a key to the human genome?Present state and future perspectives of using pluripotent stem cells in toxicology research Pluripotent stem cells: the last 10 years.Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Induced pluripotent stem cells for modelling human diseases Modelling familial dysautonomia in human induced pluripotent stem cells.Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.Induced pluripotent stem cells in the study of neurological diseases.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction.Generation of hypoxanthine phosphoribosyltransferase gene knockout rabbits by homologous recombination and gene trapping through somatic cell nuclear transfer Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.Find and replace: editing human genome in pluripotent stem cells New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells The pharmacology of regenerative medicine Trisomy correction in Down syndrome induced pluripotent stem cells.Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.AAV-mediated gene targeting methods for human cells Analysis of SOX2-expressing cell populations derived from human pluripotent stem cells A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway

P2860

Q21089894-830F788C-9774-49BC-9A0F-F5BB87FBAD48 Q21198724-E85F1DAA-D208-48CB-964F-E8368F4EC6EE Q26999310-09971181-61C5-4AC1-AB45-E7880BF4AE0B Q27001570-E9CA8FBA-0FF2-4F37-8F20-EC8A126FED55 Q30540471-D47143BE-323D-4CBB-ABE9-B0E07183B5EA Q33558379-9B22EFD3-427A-47C3-B9DF-90E778B8E327 Q33750568-7B285BC2-B957-4605-AB22-54F014B1E2E9 Q33930103-F5AED45E-5B47-48C1-8D68-5827EDB0C22E Q34080512-62C8021A-1AE9-4CAE-939C-C5D8A6D7E539 Q34082779-56DCE38F-C0D9-45BE-80EA-89674E374186 Q34110518-2D75F14A-7403-464A-B859-4D0E244730F6 Q34231818-90B4C24C-089C-47A2-BEB8-37EC2E32BA3B Q34277685-4FF2B74D-9106-4A0B-A7AA-DC0CFDF2EEF9 Q34459999-7C84DA35-11AA-40C6-B4B3-932DB0BD7108 Q34520935-3EA64ADD-AF24-48D6-80CC-9BE915B58E11 Q34546417-E1AF6A45-0CAE-4F7C-8884-3EDD2045EFD9 Q35037783-C3620FC6-3D5D-4807-B48E-26B2A7D771AD Q35088519-59210274-F6CC-40A2-A4F7-93B53A6D6819 Q35088526-61351EE1-205D-47FC-ACA5-C1F34E141FAD Q35525329-3458339F-7F80-4F07-813E-BEE91D8AF379 Q35749996-85C4CB23-82B8-48C0-B241-474FD667580D Q35775664-54648AE7-5D7D-4E0A-B2CF-D6389AE1F017 Q35823895-F45839FE-910C-4B4A-BB67-B19BF936B73B Q35840653-62C63311-07C6-433D-966A-FB6CEA946680 Q35974993-DE5D98E3-715F-4963-A838-33371A378866 Q36171903-490D5D7B-820F-4909-AF0C-3A5AF7D42312 Q36237837-5536B366-636E-4252-B3F0-E898F97FC3F0 Q36345932-E3C8D9D9-C1A2-41DC-8D52-D4328BF00824 Q36675277-AF16E2AA-7979-48BE-B067-3A4CAF34076F Q36715338-545F8B38-873B-489A-850F-F0170EFCDDC5 Q36867065-DBB917F5-5DA3-4720-BD92-ACC438C48F93 Q36922762-CBFD027B-1072-4809-8657-96777E14E51F Q36945734-4FF010B8-8EDC-42C9-9E99-F99D893C1986 Q36974665-100E8D8E-D7AA-455F-98F8-097F9EFBA218 Q36995232-BB211A66-63C9-49D0-95D9-942D038F934B Q37057699-8AE2F6AE-C9EF-489A-8D59-8D100D7CBEBF Q37085601-C1F49955-9959-4ED5-BE07-586B1C564D22 Q37344633-9C20CF44-EE6F-4C77-AB47-42B3B3A25686 Q37596293-74584FC2-630A-402A-A831-09E2494B6271 Q37649077-A2EC28F2-CF18-4273-83DC-9D5402B8C473

P2860

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

http://www.wikidata.org/entity/Q33930075

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@ast

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@en

type

label

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@ast

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@en

prefLabel

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@ast

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@en

P1433

Q33930075-EC5429CD-6AC5-4980-A4F3-185EB9EF6F44

P1476

Q33930075-CD5A7F6A-0842-4AE8-8177-20DE4104C7FF

P2093

Q33930075-032F11D5-0142-4532-99F7-E93E2AB2F2F5

Q33930075-0DE2C25B-9A9A-48FF-A42A-45D1614AB91D

Q33930075-451D53C7-1B31-4983-AF6F-C2B5F0DFA589

Q33930075-498E6ADA-9A52-4A30-A2BF-552AC74397E2

Q33930075-6FE44628-7C34-454E-BD37-940E28E50075

Q33930075-8DECD220-D1F6-4913-8EAE-6FDD3DACDA1C

Q33930075-9C18DCEC-1C31-446A-A2CD-D7751C0182C3

Q33930075-9D962016-59EC-4A78-99E0-161D5EE83321

Q33930075-C0DF337B-5677-4C30-9C83-CB9A53F3586C

P2860

Q33930075-08093E36-4E72-4317-A54D-1609B24A612B

Q33930075-0F6C3698-B960-4DC5-A779-0CA80A5B1138

Q33930075-1A6A4286-9BDD-4D3B-8F97-974D1A0231E7

Q33930075-224BF6F3-395A-4ECD-AD1F-B329522F1D47

Q33930075-257856D8-7899-4835-A114-32DD52902F7C

Q33930075-2ABF3A48-0CDA-47CD-AC0E-B8FF0C4F299E

Q33930075-2C10D65A-F3B2-4164-978A-EEA2EA65B1D7

Q33930075-390DAF1D-39C6-4663-BDAA-C278221B4CD1

Q33930075-3BF7BF76-E9DE-4CA7-A132-FD69594DCBE6

Q33930075-4E408281-271D-42E4-A6BC-4BAF6EB8E39B

P304

Q33930075-A938A76C-1CA0-4E63-A3AE-8BCFC13EDA10

P31

Q33930075-0C7CECFE-A14B-46E8-936A-83140FC1FD97

P356

Q33930075-24FD4222-902B-463B-BF21-2942C69EEFEC

P433

Q33930075-8637A9AF-3B68-4F64-AECF-5A03CBE4ECB5

P478

Q33930075-D0F26A09-E131-47A9-BB21-AB01F0FA3E95

P50

Q33930075-2D9B99A7-DDE6-4B5E-A135-FA168A994FEA

P577

Q33930075-CF73079D-4D00-4B95-A5A9-1E41644EC6B3

P5875

Q33930075-7E965DF8-2B9B-455A-A292-619EEB5425E0

P698

Q33930075-18432A57-B083-4996-B1D1-1A7CAC59735B

P932

Q33930075-52C3E499-A3B4-42E3-A315-A27E3A28C8A0

P356

P1433

Molecular Therapy

P1476

Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

@en

P2093

Angel Nelson

http://www.w3.org/2001/XMLSchema#string

Carol Ware

http://www.w3.org/2001/XMLSchema#string

Iram F Khan

http://www.w3.org/2001/XMLSchema#string

Jordan Kho

http://www.w3.org/2001/XMLSchema#string

Maja Zavaljevski

http://www.w3.org/2001/XMLSchema#string

Pei-Rong Wang

http://www.w3.org/2001/XMLSchema#string

Roli K Hirata

http://www.w3.org/2001/XMLSchema#string

Yi Li

http://www.w3.org/2001/XMLSchema#string

Yunwen Huo

http://www.w3.org/2001/XMLSchema#string

P2860

Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta

Gene targeting in stem cells from individuals with osteogenesis imperfecta

Disease-specific induced pluripotent stem cells

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Embryonic stem cell lines derived from human blastocysts

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

P304

1192-1199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.55

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

David W Russell

P577

2010-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43227321

http://www.w3.org/2001/XMLSchema#string

P698

20407427

http://www.w3.org/2001/XMLSchema#string

P932

2889726

http://www.w3.org/2001/XMLSchema#string